Search

Your search keyword '"Benchimol, Eric I."' showing total 1,061 results
Start Over Author "Benchimol, Eric I."
1,061 results on '"Benchimol, Eric I."'

2. Mental Health Experiences of Adolescents and Young Adults with Inflammatory Bowel Disease During Transition to Adult Care: A Qualitative Descriptive Study

Author

Allemang, Brooke, Browne, Mira, Barwick, Melanie, Bollegala, Natasha, Fu, Nancy, Lee, Kate, Miatello, Ashleigh, Dekker, Emily, Nistor, Irina, Ahola Kohut, Sara, Keefer, Laurie, Micsinszki, Samantha, Walters, Thomas D., Griffiths, Anne M., Mack, David R., Lawrence, Sally, Kroeker, Karen I., de Guzman, Jacqueline, Tausif, Aalia, Maini, Pranshu, Tersigni, Claudia, Anthony, Samantha J., and Benchimol, Eric I.

Published
2024
Full Text
View/download PDF

3. Validation of case-ascertainment algorithms using health administrative data to identify people who inject drugs in Ontario, Canada

Author

Greenwald, Zoë R., Werb, Dan, Feld, Jordan J., Austin, Peter C., Fridman, Daniel, Bayoumi, Ahmed M., Gomes, Tara, Kendall, Claire E., Lapointe-Shaw, Lauren, Scheim, Ayden I., Bartlett, Sofia R., Benchimol, Eric I., Bouck, Zachary, Boucher, Lisa M., Greenaway, Christina, Janjua, Naveed Z., Leece, Pamela, Wong, William W.L., Sander, Beate, and Kwong, Jeffrey C.

Published
2024
Full Text
View/download PDF

10. Health Researchers' Use of Social Media: Scoping Review.

Author

Dol, Justine, Tutelman, Perri R, Chambers, Christine T, Barwick, Melanie, Drake, Emily K, Parker, Jennifer A, Parker, Robin, Benchimol, Eric I, George, Ronald B, and Witteman, Holly O

Subjects
Humans, Research Personnel, Delivery of Health Care, Social Media, health, review, social media, Generic Health Relevance, Information and Computing Sciences, Medical and Health Sciences, Psychology and Cognitive Sciences, Medical Informatics
Abstract

BackgroundHealth researchers are increasingly using social media in a professional capacity, and the applications of social media for health researchers are vast. However, there is currently no published evidence synthesis of the ways in which health researchers use social media professionally, and uncertainty remains as to how best to harness its potential.ObjectiveThis scoping review aimed to explore how social media is used by health researchers professionally, as reported in the literature.MethodsThe scoping review methodology guided by Arksey and O'Malley and Levac et al was used. Comprehensive searches based on the concepts of health research and social media were conducted in MEDLINE, EMBASE, CINAHL, PsycINFO, ERIC, and Web of Science databases, with no limitations applied. Articles were screened at the title and abstract level and at full text by two reviewers. One reviewer extracted data that were analyzed descriptively to map the available evidence.ResultsA total of 8359 articles were screened at the title and abstract level, of which 719 were also assessed at full text for eligibility. The 414 articles identified for inclusion were published in 278 different journals. Studies originated from 31 different countries, with the most prevalent being the United States (52.7% [218/414]). The health discipline of the first authors varied, with medicine (33.3% [138/414]) being the most common. A third of the articles covered health generally, with 61 health-specific topics. Papers used a range of social media platforms (mean 1.33 [SD 0.7]). A quarter of the articles screened reported on social media use for participant recruitment (25.1% [104/414]), followed by practical ways to use social media (15.5% [64/414]), and use of social media for content analysis research (13.3% [55/414]). Articles were categorized as celebratory (ie, opportunities for engagement, 72.2% [299/414]), contingent (ie, opportunities and possible limitations, 22.7% [94/414]) and concerned (ie, potentially harmful, 5.1% [21/414]).ConclusionsHealth researchers are increasingly publishing on their use of social media for a range of professional purposes. Although most of the sentiment around the use of social media in health research was celebratory, the uses of social media varied widely. Future research is needed to support health researchers to optimize their social media use.

Published
2019

11. Variation in Testing for and Incidence of Celiac Autoimmunity in Canada: A Population-Based Study

Author

King, James A., Bakal, Jeffrey A., Li, Bing, Whitten, Tara A., Gidrewicz, Dominica, Turner, Justine M., van Zanten, Sander Veldhuyzen, Huynh, Hien Q., Heitman, Steven J., Shaheen, Abdel Aziz, Quan, Hude, Godley, Jenny, Underwood, Fox E., Hracs, Lindsay, Bergman, David, Ludvigsson, Jonas F., Lebwohl, Benjamin, Benchimol, Eric I., Williamson, Tyler, and Kaplan, Gilaad G.

Published
2023
Full Text
View/download PDF

12. Landscape of TPMT and NUDT15 Pharmacogenetic Variation in a Cohort of Canadian Pediatric Inflammatory Bowel Disease Patients

Author

Kennedy, April M, primary, Griffiths, Anne M, additional, Muise, Aleixo M, additional, Walters, Thomas D, additional, Ricciuto, Amanda, additional, Huynh, Hien Q, additional, Wine, Eytan, additional, Jacobson, Kevan, additional, Lawrence, Sally, additional, Carman, Nicholas, additional, Mack, David R, additional, deBruyn, Jennifer C, additional, Otley, Anthony R, additional, Deslandres, Colette, additional, El-Matary, Wael, additional, Zachos, Mary, additional, Benchimol, Eric I, additional, Critch, Jeffrey, additional, Schneider, Rilla, additional, Crowley, Eileen, additional, Li, Michael, additional, Warner, Neil, additional, McGovern, Dermot P B, additional, Li, Dalin, additional, Haritunians, Talin, additional, Rudin, Sarah, additional, and Cohn, Iris, additional

Published
2024
Full Text
View/download PDF

15. La déclaration RECORD (Reporting of Studies Conducted Using Observational Routinely Collected Health Data) : directives pour la communication des études réalisées à partir de données de santé collectées en routine

Author

Benchimol, Eric I, Smeeth, Liam, Guttmann, Astrid, Harron, Katie, Moher, David, Petersen, Irene, Sørensen, Henrik T, Januel, Jean-Marie, von Elm, Erik, and Langan, Sinéad M

Subjects
Health Services and Systems, Health Sciences, pour le comité de travail RECORD, Medical and Health Sciences, General & Internal Medicine, Biomedical and clinical sciences, Health sciences
Published
2019

16. HARmonized Protocol Template to Enhance Reproducibility of Hypothesis Evaluating Real-World Evidence Studies on Treatment Effects: A Good Practices Report of a Joint ISPE/ISPOR Task Force

Author

Wang, Shirley V., Pottegård, Anton, Crown, William, Arlett, Peter, Ashcroft, Darren M., Benchimol, Eric I., Berger, Marc L., Crane, Gracy, Goettsch, Wim, Hua, Wei, Kabadi, Shaum, Kern, David M., Kurz, Xavier, Langan, Sinead, Nonaka, Takahiro, Orsini, Lucinda, Perez-Gutthann, Susana, Pinheiro, Simone, Pratt, Nicole, Schneeweiss, Sebastian, Toussi, Massoud, and Williams, Rebecca J.

Published
2022
Full Text
View/download PDF

21. Inflammatory Bowel Disease Among Canadian Children: Comparison Between Children of Non-European Descent and Children of European Descent

Author

Jeong, Jocelyn, Walters, Thomas D, Huynh, Hien Q, Lawrence, Sally, Mack, David R, Deslandres, Colette, Otley, Anthony, El-Matary, Wael, Sherlock, Mary, Griffiths, Anne M, Wine, Eytan, Jacobson, Kevan, Church, Peter, Carroll, Matthew W, Benchimol, Eric I, Brill, Herbert, Critch, Jeff, Bax, Kevin, Jantchou, Prévost, Rashid, Mohsin, Kaplan, Gilaad G, Seow, Cynthia H, Novak, Kerri, and deBruyn, Jennifer C

Published
2023
Full Text
View/download PDF

22. Forecasting the Incidence and Prevalence of Inflammatory Bowel Disease: A Canadian Nationwide Analysis.

Author

Coward, Stephanie, Benchimol, Eric I., Bernstein, Charles N., Avina-Zubieta, Antonio, Bitton, Alain, Carroll, Matthew W., Yungsong Cui, Hoentjen, Frank, Hracs, Lindsay, Jacobson, Kevan, Jones, Jennifer L., King, James, Kuenzig, M. Ellen, Na Lu, El-Matary, Wael, Murthy, Sanjay K., Nugent, Zoann, Otley, Anthony R., Panaccione, Remo, and Peña-Sánchez, Juan Nicolás

Subjects
*CROHN'S disease, *BOX-Jenkins forecasting, *INFLAMMATORY bowel diseases, *ULCERATIVE colitis, *OLDER people
Abstract

INTRODUCTION: Canada has a high burden of inflammatory bowel disease (IBD). Historical trends of IBD incidence and prevalence were analyzed to forecast the Canadian burden over the next decade. METHODS: Population-based surveillance cohorts in 8 provinces derived from health administrative data assessed the national incidence (2007-2014) and prevalence (2002-2014) of IBD. Autoregressive integrated moving average models were used to forecast incidence and prevalence, stratified by age, with 95% prediction intervals (PI), to 2035. The average annual percentage change (AAPC) with 95% confidence interval (CI) was calculated for the forecasted incidence and prevalence. RESULTS: The national incidence of IBD is estimated to be 29.9 per 100,000 (95% PI 28.3-31.5) in 2023. With a stable AAPC of 0.36% (95% CI -0.05 to 0.72), the incidence of IBD is forecasted to be 31.2 per 100,000 (95% PI 28.1-34.3) in 2035. The incidence in pediatric patients (younger than 18 years) is increasing (AAPC 1.27%; 95% CI 0.82-1.67), but it is stable in adults (AAPC 0.26%; 95% CI -0.42 to 0.82). The prevalence of IBD in Canada was 843 per 100,000 (95% PI 716-735) in 2023 and is expected to steadily climb (AAPC 2.43%; 95% CI 2.32-2.54) to 1,098 per 100,000 (95% PI 1,068-1,127) by 2035. The highest prevalence is in seniors with IBD (1,174 per 100,000 in 2023; AAPC 2.78%; 95% CI 2.75-2.81). DISCUSSION: Over the next decade, the Canadian health care systems will contend with the juxtaposition of rising incidence of pediatric IBD and a rising prevalence of overall IBD driven by the aging population. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

24. Health Services Utilization and Specialist Care in Pediatric Inflammatory Bowel Disease: A Multiprovince Population-Based Cohort Study

Author

Kuenzig, M Ellen, primary, Bitton, Alain, additional, Carroll, Matthew W, additional, Otley, Anthony R, additional, Singh, Harminder, additional, Kaplan, Gilaad G, additional, Stukel, Therese A, additional, Mack, David R, additional, Jacobson, Kevan, additional, Griffiths, Anne M, additional, El-Matary, Wael, additional, Targownik, Laura E, additional, Nguyen, Geoffrey C, additional, Jones, Jennifer L, additional, Murthy, Sanjay K, additional, Bernstein, Charles N, additional, Lix, Lisa M, additional, Peña-Sánchez, Juan Nicolás, additional, Dummer, Trevor J B, additional, Spruin, Sarah, additional, Fung, Stephen G, additional, Nugent, Zoann, additional, Coward, Stephanie, additional, Cui, Yunsong, additional, Coulombe, Janie, additional, Filliter, Christopher, additional, and Benchimol, Eric I, additional

Published
2024
Full Text
View/download PDF

25. Roteiro para redação de estudos em farmacoepidemiologia conduzidos a partir de dados de saúde observacionais coletados rotineiramente (RECORD-PE), tradução para o Português

Author

Langan, Sinead, primary, Schmidt, Sigrún AJ, additional, Wing, Kevin, additional, Ehrenstein, Vera, additional, Nicholls, Stuart, additional, Filion, Kristian, additional, Klungel, Olaf, additional, Petersen, Irene, additional, Sørensen, Henrik Toft, additional, Dixon, William G, additional, Guttmann, Astrid, additional, Harron, Katie, additional, Hemkens, Lars G., additional, Moher, David, additional, Schneeweiss, Sebastian, additional, Smeeth, Liam, additional, Sturkenboom, Miriam, additional, von Elm, Erik, additional, Wang, Shirley, additional, and Benchimol, Eric I, additional

Published
2024
Full Text
View/download PDF

27. Incidence and short-term outcomes of Kawasaki disease

Author

Robinson, Cal, Chanchlani, Rahul, Gayowsky, Anastasia, Brar, Sandeep, Darling, Elizabeth, Demers, Catherine, Klowak, Jennifer, Knight, Braden, Kuenzig, Ellen, Mondal, Tapas, Parekh, Rulan, Seow, Hsien, Jimenez-Rivera, Carolina, Webster, Richard, Fung, Stephen, Benchimol, Eric I., and Batthish, Michelle

Published
2021
Full Text
View/download PDF

28. Hospitalization with Clostridioides difficile in pediatric inflammatory bowel disease: a population-based study

Author

Kuenzig, M. Ellen, Benchimol, Eric I., Bernstein, Charles N., Bitton, Alain, Carroll, Matthew W., Griffiths, Anne M., Kaplan, Gilaad G., Nguyen, Geoffrey C., Otley, Anthony R., Stukel, Therese A., Dummer, Trevor J. B., El-Matary, Wael, Jacobson, Kevan, Jones, Jennifer L., Lix, Lisa M., Mack, David R., Murthy, Sanjay K., Peña-Sánchez, Juan-Nicolás, Targownik, Laura E., Fung, Stephen G., Spruin, Sarah, Coward, Stephanie, Cui, Yunsong, Filliter, Christopher, Nugent, Zoann, Siddiq, Shabnaz, and Singh, Harminder

Published
2022
Full Text
View/download PDF

31. Bivalent mRNA SARS-CoV-2 vaccination in patients with inflammatory bowel disease

Author

Quan, Joshua, primary, Markovinović, Ante, additional, Hracs, Lindsay, additional, Ma, Christopher, additional, Panaccione, Remo, additional, Kaplan, Gilaad G, additional, Benchimol, Eric I., additional, Bernatsky, Sasha, additional, Bindra, Gurmeet, additional, Bernstein, Charles N., additional, Caplan, Léa, additional, Charlton, Carmen, additional, Coward, Stephanie, additional, Ernest-Suarez, Kenneth, additional, Herauf, Michelle, additional, Holodinsky, Jessalyn K., additional, Ingram, Richard J.M., additional, Kanji, Jamil N., additional, Kuenzig, M. Ellen, additional, Lu, Cathy, additional, Mahoney, Douglas J., additional, Novak, Kerri, additional, Rowan, Catherine, additional, Seow, Cynthia H., additional, Sharifi, Nastaran, additional, Tipples, Graham, additional, Turnbull, LeeAnn, additional, Windsor, Joseph W., additional, and Yeaman, Fiona, additional

Published
2023
Full Text
View/download PDF

34. Canadian Association of Gastroenterology Clinical Practice Guideline for the Medical Management of Pediatric Luminal Crohn's Disease

Author

Mack, David R., Benchimol, Eric I., Critch, Jeff, deBruyn, Jennifer, Tse, Frances, Moayyedi, Paul, Church, Peter, Deslandres, Colette, El-Matary, Wael, Huynh, Hien, Jantchou, Prévost, Lawrence, Sally, Otley, Anthony, Sherlock, Mary, Walters, Thomas, Kappelman, Michael D., Sadowski, Dan, Marshall, John K., and Griffiths, Anne

Published
2019
Full Text
View/download PDF

35. Upfront Combination Therapy, Compared With Monotherapy, for Patients Not Previously Treated With a Biologic Agent Associates With Reduced Risk of Inflammatory Bowel Disease-related Complications in a Population-based Cohort Study

Author

Targownik, Laura E., Benchimol, Eric I., Bernstein, Charles N., Singh, Harminder, Lix, Lisa, Tennakoon, Aruni, Leung, Stella, Aviña, Antonio, Coward, Stephanie, Jones, Jennifer, Kaplan, Gil, Murthy, Sanjay K., Nguyen, Geoffrey C., and Peña-Sánchez, Juan Nicolás

Published
2019
Full Text
View/download PDF

37. Past and Future Burden of Inflammatory Bowel Diseases Based on Modeling of Population-Based Data

Author

Coward, Stephanie, Clement, Fiona, Benchimol, Eric I., Bernstein, Charles N., Avina-Zubieta, J. Antonio, Bitton, Alain, Carroll, Mathew W., Hazlewood, Glen, Jacobson, Kevan, Jelinski, Susan, Deardon, Rob, Jones, Jennifer L., Kuenzig, M. Ellen, Leddin, Desmond, McBrien, Kerry A., Murthy, Sanjay K., Nguyen, Geoffrey C., Otley, Anthony R., Panaccione, Remo, Rezaie, Ali, Rosenfeld, Greg, Peña-Sánchez, Juan Nicolás, Singh, Harminder, Targownik, Laura E., and Kaplan, Gilaad G.

Published
2019
Full Text
View/download PDF

40. Life expectancy and health-adjusted life expectancy in people with inflammatory bowel disease

Author

Kuenzig, M. Ellen, Manuel, Douglas G., Donelle, Jessy, and Benchimol, Eric I.

Subjects
Inflammatory bowel diseases -- Care and treatment -- Patient outcomes, Life expectancy -- Forecasts and trends -- Demographic aspects, Market trend/market analysis, Health
Abstract

BACKGROUND: Inflammatory bowel disease (IBD) may be life-threatening and often reduces quality of life. We determined trends in life expectancy and health-adjusted life expectancy in people with and without IBD. METHODS: We conducted a retrospective cohort study of population-level health administrative, demographic and health survey data available from databases in Ontario. We matched people with a diagnosis of IBD to those without a diagnosis of IBD. We used period life tables that were generated using age- and sex-specific 5-year mortality rates to calculate life expectancy (for 1996, 2000, 2008 and 2011). We incorporated the Health Utility Index (National Population Health Study; Canadian Community Health Survey) to estimate health-adjusted life expectancy (for 1996, 2000 and 2008). RESULTS: Life expectancy in patients with IBD increased between 1996 and 2011 (females: from 75.5 to 78.4 yr, difference: 2.9 yr [95% confidence interval (CI) 1.3 to 4.5]; males: from 72.2 to 75.5 yr, difference: 3.2 yr [95% CI 2.1 to 4.4]). Between 1996 and 2008, health-adjusted life expectancy decreased among males by 3.9 years (95% CI 1.2 to 6.6). There was no statistically significant change in health-adjusted life expectancy among females with IBD (difference: 2.0 yr, 95% CI -1.6 to 5.7). Life expectancy and health-adjusted life expectancy were lower in people with IBD compared with those without IBD. Differences in life expectancy in people with and without IBD ranged from 6.6 to 8.1 years in females and 5.0 to 6.1 years in males, depending on the year. Differences in health-adjusted life expectancy for people with and without IBD ranged from 9.5 to 13.5 years in females and 2.6 to 6.7 years in males. INTERPRETATION: Whilst life expectancy has increased among people with IBD, a gap in life expectancy between those with and without IBD remains, and the effect of pain on daily functioning contributes substantially to reduced health-adjusted life expectancy, suggesting that improved pain mitigation strategies should be implemented., Inflammatory bowel disease (IBD), including subtypes Crohn disease and ulcerative colitis, is a chronic immune-mediated disease of the gastrointestinal tract with a relapsing and remitting course that results in stress [...]

Published
2020
Full Text
View/download PDF

42. Adalimumab vs Infliximab in Luminal Pediatric Crohn's Disease: Comparable Outcomes in a Prospective Multicenter Cohort Study.

Author

deBruyn, Jennifer C., Huynh, Hien Q., Griffiths, Anne M., Jacobson, Kevan, Mack, David, Deslandres, Colette, El-Matary, Wael, Otley, Anthony R., Church, Peter C., Lawrence, Sally, Wine, Eytan, Sherlock, Mary, Critch, Jeffrey, Benchimol, Eric I., Jantchou, Prevost, Rashid, Mohsin, Carroll, Matthew W., Bax, Kevin, Ricciuto, Amanda, and Carman, Nicholas

Published
2024
Full Text
View/download PDF

43. Outcomes Following Acute Severe Colitis at Initial Presentation: A Multi-centre, Prospective, Paediatric Cohort Study.

Author

Dhaliwal, Jasbir, Tertigas, Dominique, Carman, Nicholas, Lawrence, Sally, Debruyn, Jennifer C, Wine, Eytan, Church, Peter C, Huynh, Hien Q, Rashid, Mohsin, El-Matary, Wael, Deslandres, Colette, Critch, Jeffrey, Ricciuto, Amanda, Carroll, Matthew W, Benchimol, Eric I, Muise, Aleixo, Jacobson, Kevan, Otley, Anthony R, Vallance, Bruce, and Mack, David R

Abstract

Aim To assess contemporary outcomes in children with acute severe ulcerative colitis [ASUC] at initial presentation. Methods Between April 2014 and January 2019, children aged <17 years, with new onset ASUC (Paediatric Ulcerative Colitis Activity Index [PUCAI ≥65) were prospectively followed in a Canadian inception cohort study. 16S rRNA amplicon sequencing captured microbial composition of baseline faecal samples. Primary endpoint was corticosteroid-free clinical remission with intact colon at 1 year [PUCAI <10, no steroids ≥4 weeks]. Results Of 379 children with new onset UC/IBD-unclassified, 105 [28%] presented with ASUC (42% male; median [interquartile range; [IQR]) age 14 [11-16] years; extensive colitis in all). Compared with mild UC, gut microbiome of ASUC patients had lower α-diversity, decreased beneficial anaerobes, and increased aerobes; 54 [51%] children were steroid-refractory and given infliximab [87% intensified regimen]. Corticosteroid-free remission at 1 year was achieved by 62 [61%] ASUC cohort (by 34 [63%] steroid-refractory patients, all on biologics; by 28 [55%] steroid responders,13 [25%] on 5- aminosalicylic acid [5-ASA], 5 [10%] on thiopurines, 10 [20%] on biologics). By 1 year, 78 [74%] escalated to infliximab including 24 [47%] steroid-responders failed by 5-ASA and/or thiopurines. In multivariable analysis, clinical predictors for commencing infliximab included hypoalbuminaemia, greater PUCAI, higher age, and male sex. Over 18 months, repeat corticosteroid course[s] and repeat hospitalisation were less likely among steroid-refractory versus -responsive but -dependent patients (adjusted odds ratio [aOR] 0.71 [95% CI 0.57-0.89] and 0.54 [95% CI 0.45-0.66], respectively). Conclusion The majority of children presenting with ASUC escalate therapy to biologics. Predictors of need for advanced therapy may guide selection of optimal maintenance therapy. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

45. The 2023 Impact of Inflammatory Bowel Disease in Canada: Treatment Landscape

Author

Murthy, Sanjay K, primary, Weizman, Adam V, additional, Kuenzig, M Ellen, additional, Windsor, Joseph W, additional, Kaplan, Gilaad G, additional, Benchimol, Eric I, additional, Bernstein, Charles N, additional, Bitton, Alain, additional, Coward, Stephanie, additional, Jones, Jennifer L, additional, Lee, Kate, additional, Peña-Sánchez, Juan-Nicolás, additional, Rohatinsky, Noelle, additional, Ghandeharian, Sara, additional, Sabrie, Nasruddin, additional, Gupta, Sarang, additional, Brar, Gurmun, additional, Khan, Rabia, additional, Im, James H B, additional, Davis, Tal, additional, Weinstein, Jake, additional, St-Pierre, Joëlle, additional, Chis, Roxana, additional, Meka, Saketh, additional, Cheah, Eric, additional, Goddard, Quinn, additional, Gorospe, Julia, additional, Kerr, Jack, additional, Beaudion, Kayla D, additional, Patel, Ashley, additional, Russo, Sophia, additional, Blyth, Jonathan, additional, Blyth, Stephanie, additional, Charron-Bishop, Diane, additional, and Targownik, Laura E, additional

Published
2023
Full Text
View/download PDF

46. The 2023 Impact of Inflammatory Bowel Disease in Canada: COVID-19 and IBD

Author

Kaplan, Gilaad G, primary, Kuenzig, M Ellen, additional, Windsor, Joseph W, additional, Bernstein, Charles N, additional, Bitton, Alain, additional, Coward, Stephanie, additional, Jones, Jennifer L, additional, Lee, Kate, additional, Murthy, Sanjay K, additional, Targownik, Laura E, additional, Peña-Sánchez, Juan-Nicolás, additional, Ghandeharian, Sara, additional, Rohatinsky, Noelle, additional, Weinstein, Jake, additional, Jones May, Tyrel, additional, Browne, Mira, additional, Jannati, Nazanin, additional, Tabatabavakili, Sahar, additional, Im, James H B, additional, Meka, Saketh, additional, Vukovic, Sonya, additional, Davis, Tal, additional, Goddard, Quinn, additional, Gorospe, Julia, additional, Stocks, Taylor, additional, Caplan, Léa, additional, Kanaan, Najla, additional, Stuart, Daniel, additional, Ramsay, Tesa, additional, Robinson, Kelly J, additional, Charron-Bishop, Diane, additional, and Benchimol, Eric I, additional

Published
2023
Full Text
View/download PDF

47. The 2023 Impact of Inflammatory Bowel Disease in Canada: The Influence of Sex and Gender on Canadians Living With Inflammatory Bowel Disease

Author

Targownik, Laura E, primary, Bollegala, Natasha, additional, Huang, Vivian H, additional, Windsor, Joseph W, additional, Kuenzig, M Ellen, additional, Benchimol, Eric I, additional, Kaplan, Gilaad G, additional, Murthy, Sanjay K, additional, Bitton, Alain, additional, Bernstein, Charles N, additional, Jones, Jennifer L, additional, Lee, Kate, additional, Peña-Sánchez, Juan-Nicolás, additional, Rohatinsky, Noelle, additional, Ghandeharian, Sara, additional, Davis, Tal, additional, Weinstein, Jake, additional, Im, James H B, additional, Jannati, Nazanin, additional, Khan, Rabia, additional, Matthews, Priscilla, additional, Jones May, Tyrel, additional, Tabatabavakili, Sahar, additional, Jogendran, Rohit, additional, Hazan, Elias, additional, Browne, Mira, additional, Meka, Saketh, additional, Vukovic, Sonya, additional, Jogendran, Manisha, additional, Hu, Malini, additional, Osei, Jessica Amankwah, additional, Wang, Grace Y, additional, Sheekha, Tasbeen Akhtar, additional, Dahlwi, Ghaida, additional, Goddard, Quinn, additional, Gorospe, Julia, additional, Nisbett, Cyanne, additional, Gertsman, Shira, additional, Sousa, James, additional, Morganstein, Taylor, additional, Stocks, Taylor, additional, Weber, Ann, additional, and Seow, Cynthia H, additional

Published
2023
Full Text
View/download PDF

48. The 2023 Impact of Inflammatory Bowel Disease in Canada: Special Populations—Children and Adolescents with IBD

Author

El-Matary, Wael, primary, Carroll, Matthew W, additional, Deslandres, Colette, additional, Griffiths, Anne M, additional, Kuenzig, M Ellen, additional, Mack, David R, additional, Wine, Eytan, additional, Weinstein, Jake, additional, Geist, Rose, additional, Davis, Tal, additional, Chan, Justin, additional, Khan, Rabia, additional, Matthews, Priscilla, additional, Kaplan, Gilaad G, additional, Windsor, Joseph W, additional, Bernstein, Charles N, additional, Bitton, Alain, additional, Coward, Stephanie, additional, Jones, Jennifer L, additional, Lee, Kate, additional, Murthy, Sanjay K, additional, Targownik, Laura E, additional, Peña-Sánchez, Juan-Nicolás, additional, Rohatinsky, Noelle, additional, Ghandeharian, Sara, additional, Im, James H B, additional, Goddard, Quinn, additional, Gorospe, Julia, additional, Verdugo, Jules, additional, Morin, Samantha A, additional, Morganstein, Taylor, additional, Banning, Lisa, additional, and Benchimol, Eric I, additional

Published
2023
Full Text
View/download PDF

49. The 2023 Impact of Inflammatory Bowel Disease in Canada: Special Populations—IBD in Seniors

Author

Shaffer, Seth R, primary, Kuenzig, M Ellen, additional, Windsor, Joseph W, additional, Bitton, Alain, additional, Jones, Jennifer L, additional, Lee, Kate, additional, Murthy, Sanjay K, additional, Targownik, Laura E, additional, Peña-Sánchez, Juan-Nicolás, additional, Rohatinsky, Noelle, additional, Ghandeharian, Sara, additional, Tandon, Parul, additional, St-Pierre, Joëlle, additional, Natt, Navneet, additional, Davis, Tal, additional, Weinstein, Jake, additional, Im, James H B, additional, Benchimol, Eric I, additional, Kaplan, Gilaad G, additional, Goddard, Quinn, additional, Gorospe, Julia, additional, Bergevin, Maxime, additional, Silver, Ken, additional, Bowles, Dawna, additional, Stewart, Margaret, additional, Pearlstein, Marsha, additional, Dawson, Elizabeth H, additional, and Bernstein, Charles N, additional

Published
2023
Full Text
View/download PDF

50. The 2023 Impact of Inflammatory Bowel Disease in Canada: Access to and Models of Care

Author

Mathias, Holly, primary, Rohatinsky, Noelle, additional, Murthy, Sanjay K, additional, Novak, Kerri, additional, Kuenzig, M Ellen, additional, Nguyen, Geoffrey C, additional, Fowler, Sharyle, additional, Benchimol, Eric I, additional, Coward, Stephanie, additional, Kaplan, Gilaad G, additional, Windsor, Joseph W, additional, Bernstein, Charles N, additional, Targownik, Laura E, additional, Peña-Sánchez, Juan-Nicolás, additional, Lee, Kate, additional, Ghandeharian, Sara, additional, Jannati, Nazanin, additional, Weinstein, Jake, additional, Khan, Rabia, additional, Im, James H B, additional, Matthews, Priscilla, additional, Davis, Tal, additional, Goddard, Quinn, additional, Gorospe, Julia, additional, Latos, Kate, additional, Louis, Michelle, additional, Balche, Naji, additional, Dobranowski, Peter, additional, Patel, Ashley, additional, Porter, Linda J, additional, Porter, Robert M, additional, Bitton, Alain, additional, and Jones, Jennifer L, additional

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results